1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 28 Hits
  • 検索条件 : 絞込み (MeSH = Lung Neoplasms* / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 LU65(RCB1967) DNA replication stress and mitotic catastrophe mediate sotorasib addiction in KRASG12C-mutant cancer.
ヒト・動物細胞 LK-2(RCB1970) Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
ヒト・動物細胞 Ba/F3-CL1(RCB4474) Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.
ヒト・動物細胞 Ba/F3(RCB0805) The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics.
ヒト・動物細胞 A549(RCB0098) , HCT116(RCB2979) Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
ヒト・動物細胞 EBC-1(RCB1965) Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.
ヒト・動物細胞 293T(RCB2202) Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
ヒト・動物細胞 , 遺伝子材料 II-18(RCB2093) , tFucci(CA)2/pCSII-EF (RDB15446) L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.
実験動物マウス RBRC09497 Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
ヒト・動物細胞 PC-14(RCB0446) Suppression of non-small-cell lung cancer A549 tumor growth by an mtDNA mutation-targeting pyrrole-imidazole polyamide-triphenylphosphonium and a senolytic drug.
ヒト・動物細胞 LC-2/ad(RCB0440) Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
ヒト・動物細胞 Lu99(RCB1900) , LU65(RCB1967) Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
酵母 Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors.
ヒト・動物細胞 Ba/F3(RCB0805) Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
ヒト・動物細胞 II-18(RCB2093) Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers.
ヒト・動物細胞 PC-9(RCB4455) , Jurkat(RCB3052) A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.
ヒト・動物細胞 Ba/F3(RCB0805) , WEHI-3(RCB0035) Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.
ヒト・動物細胞 A549(RCB0098) A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity.
ヒト・動物細胞 MS-1(RCB0725) , Lu-139(RCB0469) Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.
ヒト・動物細胞 Ba/F3(RCB0805) Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.